SAMORITA HOSPITAL LIMITED

Half Yearly Financial Statements

Dear Shareholders,
We are pleased to forward herewith the unaudited Financial Statements of the company for the half year ended 31st December, 2023
as per Bangladesh Securities and Exchange Commission's notification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September
27,2009. ~
Statement of Financial Position (Un-audited)
As at 31st December, 2023 ( Figure in Taka "000")
Particular Notes December,31 June, 30
2023 2023
Assets
Non-Current Assets
Property, Plant & Equipment(WDV) 3 1,103,832 979,864
Right of Use Assets 4 1,596 2,395
Investment in Associate 5 5,965 5,944
Total Non-Current Assets 1,111,393 988,203
Current Assets:
Inventories 6 23,209 20,649
Trade Receivable 7 11,593 10,048
Advance,Deposits & Prepayments 8 8,913 13,137
Advance Income Tax 9 12,684 13,528
Cash & Cash Equivalents 10 67,835 44,366
Total Current Assets 124,234 101,728
Total Assets 1,235,627 1,089,931

Equity and Liabilities

Shareholders' Equity:
Share Capital 11 218,009 198,190
Retained Earnings 12 120,974 121,110
Revaluation Reserve 14 753,343 636,826
Dividend Equalisation Fund 13 2,955 2,955
Total Equity 1,095,281 959,081
Non- Current Liabilities :
Deferred Tax Liabilitities 15 49,438 43,051
Lease Liability 16.01 742 742
Long Term Loan 17 18,328 18,328
Total Non- Current Liabilities 68,508 62,121
Current Liabilities :
Trade Payable 18 34,887 31,813
Long Term Loan (Current Portion) 19 12,532 21,445
Lease Liability (current portion) 16.01 1,000 1,814
Other Payable 20 2,489 960
Provision & Accruals 21 10,300 6,372
Provision for Income Taxes 22 9,372 5,352
Unclaimed Dividend 23 1,258 973
Total Current Liabilities 71,837 68,729
Total Liabilities 140,346 130,850
Total Equity and Liabilities 1,235,627 1,089,931
Statement of Profit or Loss and Other Comprehensive Income (Un-audited)
For the half year ended 31st December , 2023. ( Figure in Taka "000")

Notes July, 2023 to July, 2022 to October, 2023 to October,2022 to

December, 2023 December, 2022 December, 2023 December, 2022

Revenue 25 207,737 170,913 88,390 87,982

Direct Expenses 26 (80,330) (68,793) (37,129) (35 150)
Gross Profit 127,407 102,120 51,261 52,832
Operating Expenses:
Administrative Expenses 27 (102,391) (94,248) (50,340) (48,202)
Profit from Operation 25,015 7,872 921 4,630
Share of Profit/ (loss) of Associate 24 21 17 1 2
Financial Expenses 28 (1,885) (2,541) (887) (1,222)
Non Operating Income 29 3,266 3,830 1,800 1,885
Profit before contribution to WPPF 26,417 9,178 1,835 5,295
Contribution to WPPF (1,258) (438) (87) (252)
Profit Before Tax 25,159 8,740 1,748 5,043
Income Tax Expenses (5,477) (2,005) (301) (1,050)
Current Tax 30 6,671 2,115 889 1,200
Deferred Tax 15.01 (1,194) (110) (588) (150)
Profit after Tax 19,683 6,735 1,448 3,993

Company Secretary

Page 1 of 11
 Statement of Changes In Equity (Un-audited)
For the half year ended 31st December , 2023. ( Figure in Taka "000")

Particular Share Retained Dividend Revaluation Total

Capital Earning Equalisation Fun< Reserve
Balance as at July 01,2023 198,190 121,110 2.955 636,826 959,081
Transferred to Dividend Equalisation Fund - - -
Total Comprehensive income - 19,683 19,683
Revaluation Surplus on land 124,099 124,099
Transferred to Share Capital 19,819 (19,819) -
Transferred to deferred tax liabilities (7,582) (7,582)
Balance as at December 31,2023 218,009 120,974 2,955 753,343 1,095,281

Balance as at July 01,2022 188,752 140,203 2,919 636,826 968,700

Transferred to Dividend Equalisation Fund - - -
Dividend (9,438) (9,438)
Transferred to Share Capital 9,438 (9,438) -
Total Comprehensive income - 6,735 - - 6,735
Balance as at December 31,2022 198,190 128,062 2,919 636,826 965,997

Statement of Cash Flows (Un-audited)

For the half year ended 31st December , 2023. ( Figure in Taka "000")

December,31 December,31
A. Cash flows from Operating Activities:_________ 2023 2022
Cash Received from Customers 208,551 175,555
Cash Paid to Suppliers & Employees (163,698) (148,991)
Cash generated from Operations: 44,853 26,564
Income Tax Paid _________ (1,807) ___________ (459)
Net Cash from Operating Activities 43,046 26,105
B. Cash flows from Investing Activities__________
Purchase of Property, Plant & Equipment (10,318) (18,147)
Bank Interest 286 223
FDR interest 875 1,050
Net Cash used in Investing Activities (9,157) (16,874)
C. Cash flows from Financing Activities_________
Bank Loan paid (10,705) (10,530)
Unclaimed Dividend 285 (211)
Net Cash Used in Financing Activities (10,420) (10,741)

D. Net Cash Inflows I (outflows) 23,469 (1,510)

E. Opening Cash & Bank Balance 44,366 69,462
F. Closing Cash & Bank Balance 67,835 67,952

Additional information as per listing regulation:

December,31 June,30
Particulars 2023 2023

Net Assets Value per Share (NAV) 50.24 43.99

December,31 December,31
2023 2022
Earning Per Share(EPS) 0.90 0.31
Net Operating Cash Flow Per Share(NOCFPS) 1.97 1.20

Reasons of deviation in financial parameters:

Operating results:
Operating result in the reporting period has been significantly increased due to the following reasons, compared to previous
corresponding period:
a. Revenue has been increased by Tk. 3.68 Crore.
b. Cost of direct materials has been decreased by 1.58%,
c. Administrative expenses has been decreased from 55.14% to 49.29% of revenue.
Net operating cash flow per share (NOCFPS) increased from Tk. 1.20 to Tk.1.97 due to cash receipts from customers have
been increased by Tk. 3.30 Crore.
d. Net Assets value (NAV) per share increased by Tk. 6.25 due to revaluation gain on land and usual business activities of the
company.

Managin^Director Director Chairman

"The details of the published half yearly financial statements can be available in the web-site of the company. The address of
the web-site is www.samoritahospital.org "

Page 2 of 11
 Samorita Hospital Limited
Selected Notes to the Financial Statements(Un-audited)
For the half year ended 31st December , 2023.

1.00 Legal status and nature of the Company-Disclosure under IAS-1 "Presentation of Financial Statements".
1.01 Company Profile

Samorita Hospital Limited started it's business from 01 February 1984 under the name and style as "M/s. Samorita Nursing
Home". Then it was a partnership concern and 14 October 1985 it was converted into a Private Limited Company under the
name and style as Samorita Nursing Home Ltd. Subsequently it's name and style was changed and renamed as Samorita
Hospital (Pvt.) Limited on 17 January 1990. Again on 23 June 1996 it was converted into a Public Limited Company under the
name and style as "Samorita Hospital Limited".

The company went for public issue of share in 1996 and it's shares are listed with the Stock Exchanges of Bangladesh.

1.02 Basis of preparation of Financial Statements:

These interim Financial Statements should be read in conjunction with the financial statements for the year ended 30th June,
2023 as they provide an update to previously reported information.
The Accounting Policies used are consistent with those in the Annual Financial Statements. The Financial Statements have
been prepared in accordance with the applicable International Financial Reporting Standards (IFRS). The Presentation of the
interim Financial Statements is consistent with the Annual Financial Statements.
1.03 Investment in associate Company:
The Company's investment in associate company is accounted for in the financial statements using the Equity Method in
accordance with IAS-28 "Investment in Associaties".
2.00 Specific Accounting Policies selected and applied for Significant Transactions and Events:
2.01 Accounting Convention (Measurement IASs)
The financial statements have been prepared on a going concern basis under the historical cost convention in accordance
with International Financial Reporting Standards (IFRSs) therefore, do not take into consideration the effect of inflation.

2.02 Statement of compliance

The financial statements have been prepared in accordance with the applicable International Financial Reporting Standards
(IFRSs), and The Companies Act 1994 and Securities & Exchange Rules 2020.
2.03 Reporting Currency and Level of Precision
The financial statements are presented in Bangladeshi Taka (BDT) which is the functional currency of the company. The
amounts in these financial statements have been rounded off to the nearest integer.
2.04 Risk and Uncertainties for use of estimates in preparation of Financial Statements
The preparation of Financial Statements in conformity with the International Financial Reporting Standards requires
management to make estimates and assumptions that affects the reported amounts of assets and liabilities and discloser of
contingent assets and liabilities at the date of the financial statements and revenue and expenses during the period reported.
Actual result could differ from those estimates. Estimates are used for accounting certain items such as long term contract,
provision for doubtful contracts, depreciation and amortization, Tax reserve and contingencies.
2.05 Reporting Period
The company's accounting year is July-June and this financial statements are prepared covering the period of Six months
from 01 July 2023 to 31 December 2023.
2.06 Comparative Information
Comparative information has been disclosed in respect of the period in accordance with IAS-1: Presentation of Financial
Statements, for all numeric information in the financial statements and also the narrative and descriptive information where it
is relevent for understanding of the current period's financial statements.
2.07 Recognition of Property, Plant & Equipment and Depreciation
Property, plant & equipment are recognized if it is probable that future economic benefits associated with the assets will flow
to the company and the cost of the assets can be reliably measured. All fixed assets are stated at cost or revaluation less
accumulated depreciation as per IAS-16 "Property, Plant and Equipment". No depreciation is charged on land and land
development. The cost of acquisition of an asset comprises its purchase price and any directly attributable cost of bringing the
asset to its working condition for its intended use inclusive of inward freight, duties and non-refundable taxes.The cost and
accumulated depreciation of depreciable assets retired or otherwise disposed of are subject to elimination from the assets
and accumulated depreciation and any gain or loss on such disposal will reflect in operations for the period.
2.08 Revaluation of Freehold Land
Samorita Hospital Limited revalued the freehold land on 30th September, 2023 by Basu Banerjee Nath & Co. a
Chartered Accountancy firm and the details of the revaluation of Freehold Land of the Company as under:
Revaluation gain
Current value as
(As per Book value as on Revaluation
Area of Land (Decimal) Cost per revaluation on
revaluation of the 30th June,2022 gain
30th Sept, 2023.
year 2013)
28.66 30,182,041 664,617,959 694,800,000 706,357,727 11,557,727
3.60 33,079,000 - 33,079,000 62,021,477 28,942,477
6.80 32,367,190 - 32,367,190 115,965,682 83,598,492
39.06 95,628,231 664,617,959 760,246,190 884,344,886 124,098,696
The Board of Directors adopted the valuation report in its 203rd meeting held on October 28, 2023 unanimously.

2.09 Inventories
Inventories comprise various Medicine, Material for Pathology, X-Ray, OT, Cleaning Materials, Linens, Printing and Stationery,
Materials for ECG and USG. They are stated at the lower of cost and net realizable value in accordance with IAS -2
"Inventories" after making due allowances for any obsolete or slow moving items.

Page 3 of 11
 2.10 Financial Instruments
Financial Assets
Trade Receivable
Trade receivables are recongnized and stated at original invoiced amounts and carried at anticipated realizable values.

Cash and Cash Equivalent

It includes cash in hand and cash at bank which were held and available for use by the company without any restriction and
there was insignificant risk of change in value of these current assets.

2.11 Creditors and Accrued Expenses

Liabilities are recognized for amounts to be paid in future for goods and services received, whether or not billed by the
supplier.
2.12 Taxation
Income tax expenses comprise current and deferred taxes. Income taxes are recognized in statement of profit or loss and
other comprehensive income except to the extent that relates to items recognized directly in equity or in other comprehensive
income.The Company is a publicly traded Company. As per the Income Tax Act 2023, provision for Tax has been made at the
existing rate of 22.50% in respect of business income.

Current Tax
Provision for current income tax has been made as per prescribed rate in the Finance Act, 2023 on the accounting profit
made by the company after considering some of the add backs to income and disallowances of expenditure as per income tax
laws in compliance with IAS-12:" Income Taxes".

Deferred Tax

Deferred tax liabilities are the amount of income taxes payable in future periods in respect of taxable temporary differences.
Deferred tax assets are the amount of income taxes recoverable in future periods in respect of deductible temporary
differences. Deferred tax assets and liabilities are recognized for the future tax consequences of timing differences arising
between the carrying values of assets, liabilities, income and expenditure and their respective tax bases. Deferred tax assets
and liabilities are measured using tax rates and tax laws that have been enacted or substantially enacted at the balance sheet
date. The impact on the account of changes in the deferred tax assets and liabilities has also been recognized in the
statement of comprehensive income as per IAS-12: "Income Taxes".

2.13 Revenue Recognition

In accordance with the provisions of the IFRS-15: "Revenue from Contracts with Customers"; revenue from contracts with
customers represents the amount that reflects the considerations to which entity expects to be entitled in exchange for goods
supplied and service provided to customers during the year. Revenue from contracts with customers is recognized in the
statement of profit or loss and other comprehensive income when the performance obligation (supply of promised goods and
services) is satisfied. Performance obligation is satisfied at a point in time when customer obtains the control of goods and
services. Revenue has been recognized at the time of invoice made for the services rendered by the company.

Interest income
The interest income is recognized on accrual basis as agreed terms and conditions with the banks.
Non operating income
Non operating income are recognized at the time of receive of money from other purpose than the normal course of business
of the Company.
2.14 Earnings Per Share (EPS)
The Company calculates Earnings Per Share (EPS) in accordance with IAS -33 "Earnings Per Share", which has been shown
on the face of the statement of comprehensive income. This has been calculated by dividing the basic earnings by the
number of ordinary shares outstanding during the year.
2.15 Statement of Cash Flows
Statement of Cash Flows is prepared principally in accordance with IAS -7 "Statement of Cash Flows" and the cash flow from
the operating activities have been presented under the direct method as prescribed by the Securities and Exchange Rules
1987 and considering the provision of Paragraph 19 of IAS -7 which provides that enterprise are encouraged to report "Cash
Flow from the Operating Activities using the direct Method".
2.16 Additional information on Financial Statements:
Compliance with International Financial Reporting Standards (IFRSs)
The financial statements have been prepared in compliance with requirements of IFRSs adopted by the Institute of Chartered
Accountants of Bangladesh (ICAB).
2.17 Foreign Exchange Earned and Payment
During the period the Company has not earned or made payment any amount of foreign currency.

2.18 Provisions, Contingent Liabilities and Contingent Assets (IAS-37)

There are certain pending tax claims made against the Company, which will be settled through the legal process in due
course. These are being vigorously defended by the company. The management has not considered it necessary at the
reporting date to make provisions in the financial statements in respect of any of these claims.

Accounting Assessment by Tax Liability/

Assessment Year Tax Declared Tax paid Present Status
Year Tribunal Claimed Amount
Case is Pending
2012-2013 2013-2014 13,623,217 12,843,912 13,723,217 (879,305) at High court

Case is Pending
2013-2014 2014-2015 11,669,566 15,188,234 12,879,566 2,308,668
at High court
Case is Pending
2014-2015 2015-2016 11,473,176 12,616,428 11,773,176 843,252 at Tribunal

Page 4 of 11
 Case is Pending
2015-2016 2016-2017 10,372,742 12,904,058 11,482,742 1,421,316 at High court

Case is Pending
2016-2017 2017-2018 13,918,465 14,450,494 14,433,465 17,029
at High court
As per
2017-2018 2018-2019 8,675,427 8,893,836 9,747,897 (854,061) Assesment order

Return Submited
Under Section
2018-2019 2019-2020 11,453,108 - 11,453,108 -
82BB

Case is
Pending at 2nd
2019-2020 2020-2021 3,678,790 13,143,637 9,329,484 3,814,153
appeal
(Tribunal)
Preparations
are underway
for sub-mission
2020-2021 2021-2022 13,632,068 16,541,199 11,246,630 5,294,569
of appeal
(Tribunal)

Return Submited
but Assessment
2021-2022 2022-2023 5,154,507 - 6,287,425 (1,132,918)
not yet done

Return not
2022-2023 2023-2024 2,650,892 2,837,024 (186,132)
Submited
Total 106,301,958 106,581,798 115,193,734 10,646,571

2.19 Impairment of Assets (IAS-36)

No facts and circumstances indicate that the company’s assets may be impaired. Hence, no evaluation of recoverability of
assets was performed.

2.20 Employee Benefits (IAS-19)

The Company provides short term employee benefits to its eligible employees in the form of incentive which charged as
revenue expenditure in the period to which the incentive relates.
2.21 Workers'Profit Participation and Welfare Fund:
The Company recognizes a provision for Workers' Profit Participation Fund @ 5% of net profit before Taxes in accordance
with Bangladesh Labour Law 2006.
As at As at
December, 31 June, 30
2023 2023
Figure in Taka"000
3. Property, Plant & Equipment:
Cost/Revaluation:
Land 884,346 760,247
Building 256,481 254,281
Equipments 173,570 171,170
Furniture & Fixture 29,719 29,562
Lift 21,405 17,355
Generator 7,630 7,630
Medical Oxygen System 30,078 30,078
Others 42,586 40,076
1,445,815 1,310,399
Less: Accumulated Depreciation 341,983 330,535
Written Down Value 1,103,832 979,864
4.Riaht of Use Assets
Cost 4,790 4,790
Less: Amortisation 3,194 2,395
1,596 2,395
5. Investment in Associate:
Opening Balance 5,944 5,829
Share of income / (loss)of Associate (note.24) 21 39
Prior year adjustment - 76
5,965 5,944
Share of income of Associate has been shown on the basis of unaudited report of the Imaging services Ltd. (Associate
company) for the 2nd quarter ended December 31 , 2023 in accordance with IAS-28.

Page 5 of 11
 As at As at
December, 31 June, 30
2023 2023
Figure in Taka"000'
6. Inventories:
Medical Services 4,918 4,725
Diagnostics 6,851 3,806
Pharmacy 11,440 12,118
23,209 20,649
7. Trade Receivable:
Receivable from Indoor Patient 7,011 6,003
Receivable from Outdoor Patient 1,068 698
Receivable from Institution 3,000 2,890
Rent Receivable 239 190
Receivable from FDR Interest 275 267
11,593 10,048

8. Advance, Deposits & Prepayments :

Advance for Work & others 2,306 3,216
Advance for Capital Item 2,000 3,000
Security Money & Deposit 1,538 1,538
Prepayments 3,069 5,383
8,913 13,137
9, Advance Income Tax
Opening Balance 13,528 15,788
Add: Paid during the year 1,807 2,895
15,335 18,683
Less: Adjusted during the year 2,651 5,155
Closing Balance 12,684 13,528
10. Cash & Cash Equivalents :
Cash in hand 2,388 1,658
Union Bank FDR 22,541 20,000
Cash at bank 42,906 22,708
67,835 44,366

11. Issued, Subscribed and Paid up Capital:

2,18,00,897 shares @ Tk. 10.00 each 218,009 198,190

12. Retained Earnings

Opening Balance 121,110 140,203
Less: Transfer to Share Capital 19,819 9,438
Less: Dividend Paid - 9,438
Add: Prior year adjustment of Investment of Associate - 76
Less: Prior Year Adjustment - 978
101,291 120,425
Add: Total Comprehensive Income for the year 19,683 721
120,974 121,146
Less: Transferred to Dividend Equalisation Fund - 36
120,974 121,110

13. Dividend Equalisation Fund:

Opening 2,955 2,919
Add: Addition - 36
Closing 2,955 2,955

14. Revaluation Reserve

Opening Balance 636,826 636,826
Add: Revaluation gain of land 124,099 -
Less: Transferred to Deferred tax Liabilities (note 14.01) 7,582 -
753,343 636,826
14.01. Movement in deferred tax liability
Closing Balance 35,374 27,792
Opening Balance 27,792 27,792
7,582 -
15. Deferred Tax Liabilities
Opening Balance 43,051 43,323
Add: Provision made during the year for temporary
difference(Note: 15.01) (1,194) (272)
Add: Transferred from Revaluation Reserve (note 14.01) 7,582 -
49,438 43,051
15.01 Deferred tax liability is arrived at as follows :
i. Deferred tax on PPE
Carrying amount (Accounting base) 315,116 315,246
Carrying amount (Tax base) 251,823 247,427
Taxable/(deductible) temporary difference 63,293 67,819
Permanent differences 415 415
Net TaxableZ(deductible) temporary difference 62,878 67,404
Deferred tax LiabilityZ(Assets) @ 22.50% 14,148 15,166
Page 6 of 11
 As at As at
December, 31 June, 30
2023 2023
Figure in Taka"000
Deferred tax on Right of Use Assets
Carrying amount (Accounting base) 1,596 2,395
Carrying amount (Tax base) - -
TaxableZ(deductible) temporary difference 1,596 2,395
Deferred tax LiabilityZ(Assets) @ 22.50% 359 539

Deferred tax on Lease Liabilities

Carrying amount (Accounting base) 742 742
Carrying amount (Tax base) - -
Taxable/(deductible) temporary difference (742) (742)
Deferred tax LiabilityZ(Assets) @ 22.50% (167) (167)

Deferred tax on share of profit on Investments

Carrying amount (Accounting base) 5,963 5,944
Carrying amount (Tax base) 7,335 7,335
Taxable/(deductible) temporary difference (1,372) (1,391)
Deferred tax LiabilityZ(Assets) @ 20% (274) (278)

v. Deferred tax on revaluation of property, plant and equipment:

Carrying amount (Accounting base) 884,345 694,800
Carrying amount (Tax base) - -
TaxableZ(deductible) temporary difference 884,345 694,800
Deferred tax LiabilityZ(Assets) @ 4% 35,374 27,792
Total deferred tax liability as on Dec 31, 2023 49,439 43,052

Movement of Deferred Tax on PL Items

Opening Deferred Tax Liability 15,260 15,531
ExpenseZ(lncome) during the year (1,194) (271)
Closing Deferred Tax Liability 14,065 15,260

16 Lease Liability
Opening Balance 2,556 4,079
Addition during the year - -
Finance costs during the year 93 292
Payments during the year (907) ________ (1,815)
Closing Liability 1,742 2,556

16.01 Lease Liability

Lease Liability-Current 1,000 1,814
Lease Liability-Non Current 742 742
1,742 2,556

17. Long Term Loan

a. Principal Amount
Opening Balance 39,773 55,000
Add: Addition during the year - -
39,773 55,000
Less: Repayment 8,913 15,227
Total 30,860 39,773
b. Interest Amount
Opening Balance - 1,551
Add: Addition during the year 1,792 4,332
1,792 5,883
Less: Reoavment 1,792 5,883
Total - -
Closing Balance 30,860 39,773
Less: Long Term Loan (Current Portion) 12,532 21,445
Total _________ 18,328 _________ 18,328

All fixed and floating assets are mortgaged against long term loan.

18. Trade Payable:

Advance Receipt from Patient 1,419 1,076
Advance Receipt from MTB & Others 449 539
Current Liability for Expenses 839 733
Current Liabilities for Supply 16,949 15,493
Workers profit participation fund (note 18.01) 15,231 13,973
34,887 _________ 31,813
Page 7 of 11 =
 As at As at
December, 31 June, 30
2023 2023
Figure in Taka"000"

18.01. Workers profit participation fund :

Opening Balance 13,973 14,770
Less: Paid During the year 2,377
13,973 12,393
Add: Provision made during the year 1,258 155
Add: Interest Charged for the year 1,425
15,231 13,973

19. Long Term Loan (Current Portion)

Closing Balance 12,532 _________ 21,445

20. Other Payables

Suppliers & Others Vat 1226 514
Suppliers & Others Tax 995 446
Managing Directors Salary Tax 268 -
__________ 2,489 960

21. Provision & Accruals:

Utility Bills 1,373 1,912

Salary & Allowance 8,766 4,156
Others 161 304
_________ 10,300 __________ 6,372

22. Provision for Income Taxes

Opening Balance 5,352 7,856
Less: Adjusted during the year (Note-9) 2,651 5,155
2,701 2,701
Less: Paid During the Year - -
2,701 2,701
Add: Provision made during the year 6,671 2,651
__________ 9,372 __________ 5,352

23. Unclaimed Dividend

Opening Balance 973 1,172

Add : Addition during the year 285 982
1,258 2,154
Less: Capital Market Stablization Fund - 1,172
Less: Paid during the year - ______________ 9_
__________ 1,258 ____________ 973

The Above amount of Tk.973,000 has been unclaimed for the financial year 2020-2021. As per BSEC Directive No.
BSEC/CMRRCD/2021-386/03 dt.January 14, 2021 the amount shall be payable to CMFS as soon as the expiry of 3 years.
Hence the amount shall be payable to CMSF on 29th December, 2024.

December, 31 December, 31
2023 2022
Figure in Taka"000"
24. Share of Profit I (loss) of Associate :
Net profit/ (loss) of Associate company

Share of Profit/ (loss) of Associate company

(45% of Tk. 47 )
25. Revenue

Medical Services 96,633 75,513

Diagnostic 55,175 45,954
Pharmacy 55,929 49,446
207,737 170,913

26. Direct Expenses:

Medical Services 17,328 15,082

Diagnostic 20,697 17,371
Pharmacy 42,305 36,340
80,330 68,793

Page 8 of 11
 December, 31 December, 31
2023 2022
Figure in Taka"000'
27. Administrative Expenses:
Salary & Allowance 54,468 50,146
Managing Director's Salary 4,140 4,116
Utility Bills 11,193 9,107
Repair 2,159 4,461
Depreciation 11,449 11,254
Depreciation on Right of Use Assets 798 798
Printing 1,086 1,034
Bad debt 380 117
Others 16,718 13,215
102,391 _________ 94,248

28.Financial Expenses
Interest on Term Loan 1,792 2,378
Interest on Lease Liability 93 163
1,885 2,541

29. Non Operatina Income

Rent Received 1,590 1,741
FDR Interest 883 1,079
Bank Interest 286 223
Referral Income 327 327

Others 180 460

__________ 3,266 __________ 3,830

30. Current year's Tax 6,671 2,115

i. Regular Tax
Net profit before tax as per profit & loss Account 25,159 8,740
Less: Profit/(Loss) from Investments 21 17
25,138 8,723

Add: Items of charges to be considered separately:

Accounting depreciation 11,449 11,254
Depreciation on RoU Assets 798 798
Finance Cost on Lease Liabilities 93 163
12,340 12,215

Less: Admissible items:

Payments for Leases 907 907
Tax depreciation 6,922 10,634
7,829 _______ 11,541

Total business income during the year 29,649 9,397

Regular Tax on business income @ 22.5% 6,671 2,115

6,671 __________ 2,115

31. Special disclosure as per notification No. BSEC/CMRRCD/2006-158/208/Admin/81 is as under:

As at As at
December, 31 June, 30
a ) Detailed break-up of shareholders equity: 2023 2023
Figure in Taka"000"
Share Capital (note- a.01) 218,009 198,190
Retained Earnings (note- a.02) 120,974 121,110
Revaluation Reserve (note- a.03) 753,343 636,826
Dividend Equalisation Fund 2,955 2,955
Total Equity 1,095,281 ________ 959,081

Page 9 of 11
 a.01 , Paid-up capital:
Figure in Taka"000"
Type of Share No. of Shares Face value Issu Date
Ordinary Share 6,000 10.00 10/11/1997 60,000 60,000
Bonus Share 600 10.00 23/04/2005 6,000 6,000
Bonus Share 990 10.00 26/01/2010 9,900 9,900
Bonus Share 1,214 10.00 08/02/2012 12,140 12,140
Bonus Share 1,584 10.00 24/01/2013 15,844 15,844
Bonus Share 3,117 10.00 26/01/2014 31,170 31,170
Bonus Share 1,351 10.00 07/01/2015 13,510 13,510
Bonus Share 1,486 10.00 26/12/2016 14,860 14,860
Bonus Share 1,634 10.00 28/12/2017 16,340 16,340
Bonus Share 899 10.00 05/01/2020 8,988 8,988
Bonus Share 944 10.00 09/01/2023 9,438 9,438
Bonus Share 1,982 10.00 15/01/2024 19,819 -
Total: 21,800,897 shares @ Tk. 10.00 each 218,009 ____ 198,190

a.02 , Retained Earnings

Opening Balance 121,110 140,203

Less: Dividend Paid - 9,438
Less: Transfer to Share Capital 19,819 9,438
Add: Prior year adjustment of Investment of Associate - 76
Less: Prior Year Adjustment - 978
101,291 120,425
Add: Total Comprehensive Income for the year 19,683 721
120,974 121,146
Less: Transferred to Dividend Equalisation Fund - 36
Retained Earnings ________ 120,974 ________ 121,110

As at As at
December, 31 June, 30
2023 2023
Figure in Taka"000"

a.03, Revaluation Reserve

Opening Balance 636,826 636,826
Add: Revaluation gain of land 124,099
Less: Transferred to Deferred tax Liabilities (note 14.01) 7,582
753,343 636,826

b) Net Asset Value Per Share (NAV)

Total Assets 1,235,627 1,089,931
Less Total liabilities : 140,346 130,850
Non Current Liabilities 68,508 62,121
Current Liabilities 71,837 68,729
Net Assets: 1,095,281 959,081
Number of outstanding shares at the year end 21,801 21,801
Net Asset Value Per Share (NAV) 50.24 43.99

December, 31 December, 31
c) Basic and diluted Earnings Per Share: 2023 2022
Besic Earning Per Share: Figure in Taka"000"
Profit Attributable to ordinary shareholders 19,683 6,735
Number of outstanding shares at the year end 21,801 21,801
Basic Earning per Share (EPS) 0.90 ___________ 0.31

Diluted Earning Per Share:

Diluted EPS is determined by adjusting the Profit or loss attributable to ordinary shareholders and the weighted average
number of ordinary shares outstanding, for the effects of all dilutive potential ordinary shares. However, dilution of EPS is not
applicable for these financial statements as there was no potential dilutive ordinary share during the relevant period.

d) Net operating cash flows per share (NOCFPS)

Net Cash from Operating Activities 43,046 26,105

Number of outstanding shares at the year end 21,801 21,801
Net operating cash flows per share (NOCFPS) 1.97 1.20

Page 10 of 11
 e) Reconciliation of Net profit with Cash Flows from Operating Activities
For the half year ended December 31, 2023

Particulars December, 31 December, 31

2023 2022
Figure in Taka"000
Profit Before Tax 25,159 8,740
Depreciation 12,247 12,052
Bad debt 380 117
(Gain) / Loss on Disposal - -
FDR Interest (883) (1,079)
Bank Interest (286) (223)
Investment Income (Share of (Profit) /Loss of Associate) (21) (17)
Financial Charges 1,885 2,541
Payment for lease (907) (907)
(lncrease)/Decrease in Inventories (2,560) (7,990)
(Increase)ZDecrease in Trade and other receivable (1,537) (259)
(Increase)ZDecrease in Advance, Deposits & Prepayment 3,224 1,605
lncrease/(Decrease) in Trade Payable 1,816 8,790
IncreaseZ(Decrease) in other Payable 1,529 2,182
IncreaseZ(Decrease) in Provision & accruals 3,549 573
IncreaseZ(Decrease) in WPPF 1,258 438
Cash Flows from operation 44,853 26,564
Tax Paid (1,807) (459)
43,046. 26,105

32. Related Party Disclosures (IAS-24):

as on 31st December 2023 ( Figure in Taka "000")

SL.N Basis of Total Transaction

Particulars Nature of Relation Outstanding
0 transactions Value
1.00 Nurse Hostel Mrs. Latifa Haroon, Space rent as per 907 -
W/O Dr.A B M Haroon contract
2.00 The Imaging Services Associate company Space rent as per 504 229
Ltd. contract

3.00 Purabi General Common director Insurance 160 -

Insurance Company Premium as per
Limited contract
4.00 M.H. Samorita Hospital Common director Pathology Test as 859 873
& Medical College per negotiation

December, 31 June, 30
2023 2023
Figure in Taka"000"
33. Discolosure of key management personnel compensation:
Detailed discolosure regarding the compensation packages of key management personnel is presented below.
Key management are those persones having authority and responsibility for planing, Directing and controlling the
activities of the company.
i) Remuneration and Meeting fees for Non-exceutive directors

Remuneration & Other benefits - -

Board meeting fees 232 440
232 440
ii) Compensation of key management personnel
a) Short-term employee benefits 6,227 17,078
b) Post-employment benefits - -
c) Other long-term benefits - -
d) Termination benefits - -
e) Share-based payment - -
6,227 17,078

Shortterm employee benefits consisted of salary, bonus, medical allowance, housing, cars, fees or subsidized
goods or services for key management personnel.
Key management personel includes Managing Director, Company Secretary, Chief Financial Officer, Head of
Internal Audit and Compliance, Head of Administration and Human Resources and Chief Medical Officer.

CFO Company Secretary Managing iSi rector Director Chairman

Page 11 of 11